1. 1) Doggrell SA, Hancox JC. Dronedarone: an amiodarone analogue. Expert Opin. Investig. Drugs, 13, 415–426 (2004).
2. 2) Hohnloser SH, Connolly SJ, Crijns HJ, Page RL, Seiz W, Torp-Petersen C. Rationale and design of ATHENA: A placebo-controlled, double-blind, parallel arm trial to assess the efficacy of dronedarone 400 mg bid for the prevention of cardiovascular hospitalization or death from any cause in patients with atrial fibrillation/atrial flutter. J. Cardiovasc. Electrophysiol., 19, 69–73 (2008).
3. 3) Multaq® FDA Clinical pharmacology and biopharmaceutics reviews, 2009.
4. 4) Abramovici B, Gautier JC, Gromenil JC, Marrier JM. Tablet form for oral administration of amiodarone hydrochloride or dronedarone hydrochloride; antiarrhythmic agents, U.S.7323493 (1998).
5. 5) Gursoy RN, Benita S. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomed. Pharmacother, 58, 173–182 (2004).